Matches in Wikidata for { <http://www.wikidata.org/entity/Q90116390> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q90116390 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q90116390 description "scientific article published on 08 July 2019" @default.
- Q90116390 description "wetenschappelijk artikel" @default.
- Q90116390 description "наукова стаття, опублікована 8 липня 2019" @default.
- Q90116390 name "Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179" @default.
- Q90116390 name "Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179" @default.
- Q90116390 type Item @default.
- Q90116390 label "Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179" @default.
- Q90116390 label "Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179" @default.
- Q90116390 prefLabel "Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179" @default.
- Q90116390 prefLabel "Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179" @default.
- Q90116390 P1433 Q90116390-DACB2F93-07B5-439F-96BD-D6F0439BE4AC @default.
- Q90116390 P1476 Q90116390-3880587E-8C99-4AD5-95FF-586586BA5A49 @default.
- Q90116390 P2093 Q90116390-534D446B-715B-495A-8750-07044B9ADB5D @default.
- Q90116390 P2093 Q90116390-57DA4CBE-DA89-4052-AC35-B35A81580AED @default.
- Q90116390 P2093 Q90116390-912C7D06-54A6-40E5-AA86-CBA0DC017FA7 @default.
- Q90116390 P2093 Q90116390-E1995146-8FEE-4F4C-AE1B-0A0F01D65753 @default.
- Q90116390 P31 Q90116390-11519642-2039-4663-A457-DA3AEE522BE7 @default.
- Q90116390 P356 Q90116390-ED1E4846-7748-4F16-B25C-000E7ACF63B0 @default.
- Q90116390 P577 Q90116390-C8C068CD-2CEC-4704-813C-1D9C52D54ED4 @default.
- Q90116390 P698 Q90116390-189EB4F2-D56B-4AA9-A265-5855A6869E8E @default.
- Q90116390 P921 Q90116390-439B22FF-B318-4443-AA0E-0D540AEC6703 @default.
- Q90116390 P921 Q90116390-6D20E06E-53CF-47CA-9139-8350CB9EF8A3 @default.
- Q90116390 P356 J.CLLC.2019.06.009 @default.
- Q90116390 P698 32143966 @default.
- Q90116390 P1433 Q332299 @default.
- Q90116390 P1476 "Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179" @default.
- Q90116390 P2093 "Bilal Anouti" @default.
- Q90116390 P2093 "Greg Durm" @default.
- Q90116390 P2093 "Nasser Hanna" @default.
- Q90116390 P2093 "Sandra Althouse" @default.
- Q90116390 P31 Q13442814 @default.
- Q90116390 P356 "10.1016/J.CLLC.2019.06.009" @default.
- Q90116390 P577 "2019-07-08T00:00:00Z" @default.
- Q90116390 P698 "32143966" @default.
- Q90116390 P921 Q13896859 @default.
- Q90116390 P921 Q3658562 @default.